$LEXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LEXICON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in LEXICON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.33 | 1,000 | 2,330 | 18,345 | 17.3 K to 18.3 K (+5.77 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.32 | 1,000 | 2,320 | 17,345 | 16.3 K to 17.3 K (+6.12 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.31 | 1,600 | 3,696 | 16,345 | 14.7 K to 16.3 K (+10.85 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.30 | 400 | 920 | 14,745 | 14.3 K to 14.7 K (+2.79 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.28 | 500 | 1,140 | 14,345 | 13.8 K to 14.3 K (+3.61 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.27 | 200 | 454 | 13,845 | 13.6 K to 13.8 K (+1.47 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.25 | 601 | 1,352 | 13,645 | 13 K to 13.6 K (+4.61 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.40 | 3,000 | 4,194 | 127,539 | 124.5 K to 127.5 K (+2.41 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.36 | 16,000 | 21,760 | 124,539 | 108.5 K to 124.5 K (+14.74 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.35 | 3,500 | 4,725 | 108,539 | 105 K to 108.5 K (+3.33 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.35 | 600 | 807 | 105,039 | 104.4 K to 105 K (+0.57 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.34 | 6,600 | 8,844 | 104,439 | 97.8 K to 104.4 K (+6.75 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.34 | 100 | 134 | 97,839 | 97.7 K to 97.8 K (+0.10 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.33 | 10,044 | 13,359 | 97,739 | 87.7 K to 97.7 K (+11.45 %) |
Aug 20 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 1.33 | 156 | 207 | 87,695 | 87.5 K to 87.7 K (+0.18 %) |
Aug 02 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | P | 1.14 | 10,000 | 11,400 | 43,368 | 33.4 K to 43.4 K (+29.97 %) |
Aug 02 2019 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | P | 1.18 | 12,000 | 14,160 | 52,187 | 40.2 K to 52.2 K (+29.86 %) |
Aug 02 2019 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | P | 1.17 | 12,000 | 14,040 | 40,187 | 28.2 K to 40.2 K (+42.57 %) |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 9,555 | 0 | 19,110 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,798 | 0 | 5,595 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 4,495 | 0 | 4,495 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 0 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 5.51 | 8,639 | 47,601 | 72,508 | 81.1 K to 72.5 K (-10.65 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 9,555 | 0 | 81,147 | 71.6 K to 81.1 K (+13.35 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,798 | 0 | 71,592 | 68.8 K to 71.6 K (+4.07 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 4,495 | 0 | 68,794 | 64.3 K to 68.8 K (+6.99 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 64,299 | 58.5 K to 64.3 K (+9.93 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 19,453 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 5,980 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,727 | 0 | 14,979 | 5.3 K to 15 K (+185.21 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 5,252 | 2.3 K to 5.3 K (+132.18 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 4,213 | 0 | 8,427 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,270 | 0 | 2,540 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 2,075 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,668 | 0 | 0 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 5.51 | 2,501 | 13,781 | 33,368 | 35.9 K to 33.4 K (-6.97 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 4,213 | 0 | 35,869 | 31.7 K to 35.9 K (+13.31 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,270 | 0 | 31,656 | 30.4 K to 31.7 K (+4.18 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 30,386 | 28.3 K to 30.4 K (+7.33 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,668 | 0 | 28,311 | 25.6 K to 28.3 K (+10.40 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 8,463 | 0 | 16,927 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,593 | 0 | 5,185 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,352 | 0 | 2,353 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 5.51 | 4,544 | 25,037 | 14,161 | 18.7 K to 14.2 K (-24.29 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 8,463 | 0 | 18,705 | 10.2 K to 18.7 K (+82.63 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,593 | 0 | 10,242 | 7.6 K to 10.2 K (+33.90 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,352 | 0 | 7,649 | 5.3 K to 7.6 K (+44.40 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 8,297 | 0 | 16,593 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,498 | 0 | 4,995 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 4,085 | 0 | 4,085 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 5,271 | 0 | 0 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 5.51 | 6,885 | 37,936 | 67,067 | 74 K to 67.1 K (-9.31 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 8,297 | 0 | 73,952 | 65.7 K to 74 K (+12.64 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,498 | 0 | 65,655 | 63.2 K to 65.7 K (+3.96 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 4,085 | 0 | 63,157 | 59.1 K to 63.2 K (+6.92 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 5,271 | 0 | 59,072 | 53.8 K to 59.1 K (+9.80 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 8,570 | 0 | 17,140 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,585 | 0 | 5,170 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,227 | 0 | 4,228 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 0 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 5.51 | 6,809 | 37,518 | 47,098 | 53.9 K to 47.1 K (-12.63 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 8,570 | 0 | 53,907 | 45.3 K to 53.9 K (+18.90 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,585 | 0 | 45,337 | 42.8 K to 45.3 K (+6.05 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,227 | 0 | 42,752 | 38.5 K to 42.8 K (+10.97 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 38,525 | 34 K to 38.5 K (+13.39 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 23,513 | 0 | 47,027 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 5,363 | 0 | 10,725 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 8,390 | 0 | 8,390 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,835 | 0 | 0 | |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 5.51 | 18,641 | 102,712 | 87,539 | 106.2 K to 87.5 K (-17.56 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 23,513 | 0 | 106,180 | 82.7 K to 106.2 K (+28.44 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 5,363 | 0 | 82,667 | 77.3 K to 82.7 K (+6.94 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 8,390 | 0 | 77,304 | 68.9 K to 77.3 K (+12.17 %) |
Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,835 | 0 | 68,914 | 58.1 K to 68.9 K (+18.66 %) |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 26,510 | 0 | 26,510 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 5.16 | 39,770 | 205,213 | 39,770 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 79,800 | 0 | 79,800 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 5.16 | 148,200 | 764,712 | 148,200 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 0.00 | 68,560 | 0 | 68,560 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 5.16 | 127,320 | 656,971 | 127,320 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 0.00 | 67,120 | 0 | 67,120 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 5.16 | 124,640 | 643,142 | 124,640 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 0.00 | 70,390 | 0 | 70,390 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 5.16 | 130,710 | 674,464 | 130,710 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 0.00 | 75,870 | 0 | 75,870 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 5.16 | 140,900 | 727,044 | 140,900 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.00 | 238,140 | 0 | 238,140 | |
Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 5.16 | 442,260 | 2,282,062 | 442,260 | |
Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 57,724 | 718,935 | 3,516,214 | 3.5 M to 3.5 M (+1.67 %) |
Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.54 | 125,114 | 1,568,442 | 3,458,490 | 3.3 M to 3.5 M (+3.75 %) |
Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.95 | 228,264 | 2,955,083 | 3,333,376 | 3.1 M to 3.3 M (+7.35 %) |
Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.36 | 25,461 | 340,090 | 3,105,112 | 3.1 M to 3.1 M (+0.83 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.27 | 51,600 | 684,613 | 3,079,651 | 3 M to 3.1 M (+1.70 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.28 | 12,391 | 164,613 | 3,028,051 | 3 M to 3 M (+0.41 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.45 | 8,982 | 120,819 | 3,015,660 | 3 M to 3 M (+0.30 %) |
Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.06 | 36,584 | 477,937 | 3,006,678 | 3 M to 3 M (+1.23 %) |
Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.66 | 9,200 | 116,462 | 2,970,094 | 3 M to 3 M (+0.31 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.83 | 107,023 | 1,373,244 | 2,960,894 | 2.9 M to 3 M (+3.75 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.75 | 98,626 | 1,257,452 | 2,853,871 | 2.8 M to 2.9 M (+3.58 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.89 | 29,747 | 383,427 | 2,755,245 | 2.7 M to 2.8 M (+1.09 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 10.15 | 10,000 | 101,500 | 11,428 | |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 12.91 | 10,000 | 129,076 | 25,643 | 35.6 K to 25.6 K (-28.06 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 10.15 | 10,000 | 101,500 | 35,643 | 25.6 K to 35.6 K (+39.00 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.93 | 57,439 | 742,508 | 2,725,498 | 2.7 M to 2.7 M (+2.15 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.58 | 95,079 | 1,196,370 | 2,668,059 | 2.6 M to 2.7 M (+3.70 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 173,121 | 2,156,187 | 2,572,980 | 2.4 M to 2.6 M (+7.21 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.24 | 121,803 | 1,490,576 | 2,399,859 | 2.3 M to 2.4 M (+5.35 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.22 | 147,339 | 1,800,041 | 2,278,056 | 2.1 M to 2.3 M (+6.91 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 11.62 | 147,339 | 1,712,050 | 2,130,717 | 2 M to 2.1 M (+7.43 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.32 | 147,339 | 1,521,025 | 1,983,378 | 1.8 M to 2 M (+8.02 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.32 | 147,339 | 1,521,025 | 1,983,378 | 1.8 M to 2 M (+8.02 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.84 | 147,339 | 1,450,420 | 1,836,039 | 1.7 M to 1.8 M (+8.72 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.84 | 147,339 | 1,450,420 | 1,836,039 | 1.7 M to 1.8 M (+8.72 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.62 | 138,700 | 1,334,974 | 1,688,700 | 1.6 M to 1.7 M (+8.95 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.62 | 138,700 | 1,334,974 | 1,688,700 | 1.6 M to 1.7 M (+8.95 %) |
May 25 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | P | 9.78 | 745 | 7,286 | 5,297 | 4.6 K to 5.3 K (+16.37 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Grant | A | 0.00 | 2,564 | 0 | 13,044 | 10.5 K to 13 K (+24.47 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Grant | A | 0.00 | 2,564 | 0 | 13,616 | 11.1 K to 13.6 K (+23.20 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Grant | A | 0.00 | 2,564 | 0 | 28,187 | 25.6 K to 28.2 K (+10.01 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,797 | 0 | 8,393 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 4,495 | 0 | 8,990 |